Braxia Scientific
在场
Braxia Scientific 是一家在股票代码 BRAX (CA) 下上市的公司。
高管
查看带有其 7 名主要高管的组织结构图
Braxia Scientific 搜索最多的简介
高管在Braxia Scientific变化
- Peter Rizakos 曾任 Chief Legal Officer, 现任 Chief Legal Officer and Director (新闻发布的2024十一月19号).
- Jerry Habuda, Director, 已经离开公司 (新闻发布的2024十一月19号).
创建提醒
跟踪 Braxia Scientific 的高管变动
生物技术
Braxia Scientific 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
Braxia Scientific 的最新新闻稿
- Braxia Scientific Reports Fiscal 2023 Financial Results - Braxia Scientific Corp.
- Braxia Scientific Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic - Braxia Scientific Corp.
- Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America - Braxia Scientific Corp.
- Braxia Scientific Launches KetaMD in Florida; First Patients Complete Initial Virtual Ketamine Treatments At-Home - Braxia Scientific Corp.
- Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 - Braxia Scientific Corp.
- Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients - Braxia Scientific Corp.
- Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with Plans to Expand Across the U.S. - Braxia Scientific Corp.
- Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results - Braxia Scientific Corp.
- Braxia Scientific Bolsters Leadership with Strategic Hires; Adds Chief Information Officer and Global Pharmaceutical Industry Leader as VP R&D and Growth - Braxia Scientific Corp.
- Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond - Braxia Scientific Corp.
- View more press releases Close
通过电子邮件
